Skip to main content
. 2022 Feb 28;234:114239. doi: 10.1016/j.ejmech.2022.114239

Fig. 5.

Fig. 5

The pharmacological mechanisms of thalidomide. Thalidomide arrests multiple myeloma (MM) cells in the G1 phase by inhibiting adhesion of MM cells to bone-marrow stromal cells [132].